[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[S. 2645 Reported in Senate (RS)]

<DOC>





                                                       Calendar No. 474
115th CONGRESS
  2d Session
                                S. 2645

 To establish a demonstration program under which the Drug Enforcement 
Administration provides grants to certain States to enable those States 
         to increase participation in drug take-back programs.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                             April 11, 2018

 Mrs. Ernst (for herself, Mr. Grassley, Mr. Blumenthal, and Mr. Coons) 
introduced the following bill; which was read twice and referred to the 
                       Committee on the Judiciary

                             June 19, 2018

              Reported by Mr. Grassley, without amendment

_______________________________________________________________________

                                 A BILL


 
 To establish a demonstration program under which the Drug Enforcement 
Administration provides grants to certain States to enable those States 
         to increase participation in drug take-back programs.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Access to Increased Drug Disposal 
Act of 2018''.

SEC. 2. DEFINITIONS.

    In this Act--
            (1) the term ``Attorney General'' means the Attorney 
        General, acting through the Assistant Attorney General for the 
        Office of Justice Programs;
            (2) the term ``authorized collector'' means a narcotic 
        treatment program, a hospital or clinic with an on-site 
        pharmacy, a retail pharmacy, or a reverse distributor, that is 
        authorized as a collector under section 1317.40 of title 21, 
        Code of Federal Regulations (or any successor regulation);
            (3) the term ``covered grant'' means a grant awarded under 
        section 3; and
            (4) the term ``eligible collector'' means a person who is 
        eligible to be an authorized collector.

SEC. 3. AUTHORITY TO MAKE GRANTS.

    The Attorney General shall award grants to States to enable the 
States to increase the participation of eligible collectors as 
authorized collectors.

SEC. 4. APPLICATION.

    A State desiring a covered grant shall submit to the Attorney 
General an application that, at a minimum--
            (1) identifies the single State agency that oversees 
        pharmaceutical care and will be responsible for complying with 
        the requirements of the grant;
            (2) details a plan to increase participation rates of 
        eligible collectors as authorized collectors; and
            (3) describes how the State will select eligible collectors 
        to be served under the grant.

SEC. 5. USE OF GRANT FUNDS.

    A State that receives a covered grant, and any subrecipient of the 
grant, may use the grant amounts only for the costs of installation, 
maintenance, training, purchasing, and disposal of controlled 
substances associated with the participation of eligible collectors as 
authorized collectors.

SEC. 6. ELIGIBILITY FOR GRANT.

    The Attorney General shall award a covered grant to 5 States, not 
less than three of which shall be States in the lowest quartile of 
States based on the participation rate of eligible collectors as 
authorized collectors, as determined by the Attorney General.

SEC. 7. DURATION OF GRANTS.

    The Attorney General shall determine the period of years for which 
a covered grant is made to a State.

SEC. 8. ACCOUNTABILITY AND OVERSIGHT.

    A State that receives a covered grant shall submit to the Attorney 
General a report, at such time and in such manner as the Attorney 
General may reasonably require, that--
            (1) lists the ultimate recipients of the grant amounts;
            (2) describes the activities undertaken by the State using 
        the grant amounts; and
            (3) contains performance measures relating to the 
        effectiveness of the grant, including changes in the 
        participation rate of eligible collectors as authorized 
        collectors.

SEC. 9. DURATION OF PROGRAM.

    The Attorney General may award covered grants for each of the first 
5 fiscal years beginning after the date of enactment of this Act.

SEC. 10. AUTHORIZATION OF APPROPRIATIONS.

    There are authorized to be appropriated to the Attorney General 
such sums as may be necessary to carry out this Act.
                                                       Calendar No. 474

115th CONGRESS

  2d Session

                                S. 2645

_______________________________________________________________________

                                 A BILL

 To establish a demonstration program under which the Drug Enforcement 
Administration provides grants to certain States to enable those States 
         to increase participation in drug take-back programs.

_______________________________________________________________________

                             June 19, 2018

                       Reported without amendment